Empagliflozin in Pulmonary Arterial Hypertension

Summary

The aim of the study is to determine whether conducting a randomized placebo-controlled clinical trial is feasible, safe for the patient and whether the treatment is well tolerated in patients with idiopathic pulmonary arterial hypertension.

Timeline

Start

2023-03-01

Primary completion

2024-11-01

Completion

2024-11-01

Drugs

Indications